Jianing Chen

Dr. Jianing Chen


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 December 2023 in Nature
Verified
Journal Article
Closed access
PDF file
DHDi Huang
Di Huang
XZXiaofeng Zhu
Xiaofeng Zhu
SYShuying Ye
Shuying Ye
JZJiahui Zhang
Jiahui Zhang
JLJianyou Liao
Jianyou Liao
ESErwei Song
Erwei Song

22 November 2022 in Oncogene
Verified
Journal Article
Open access
PDF file
WZWenfeng Zeng
Wenfeng Zeng
LXLixiong Xiong
Lixiong Xiong
WWWei Wu
Wei Wu
SLShunrong Li
Shunrong Li
JLJiang Liu
Jiang Liu
DHDi Huang
Di Huang
The heterogeneity of cancer-associated fibroblasts (CAFs) might be ascribed to differences in origin. CD10 and GPR77 have been reported to identify a chemoresistance-inducing CAF subset in breast cancer. However, the precise mechanism for the formation of the CD10+GPR77+ CAFs remains unknown. In this study, we found that CCL18 expression was positively correlated with the density of CD10+GPR77+ CAFs in breast cancer and associated with a poor response to chemotherapy. Moreover, CCL18 secreted by tumor-associated macrophages (TAMs) activated a CD10+GPR77+ CAF phenotype in normal breast-resident fibroblasts (NBFs), which could then enrich cancer stem cells (CSCs) and induce chemoresistance in breast cancer cells. Mechanistically, CCL18 activated NF-κB signaling via PITPNM3 and thus enhanced the production of IL-6 and IL-8. Furthermore, intratumoral CCL18 injection significantly induced the activation of NBFs and the chemoresistance of xenografts in vivo. In addition, targeting CCL18 by anti-CCL18 antibody could inhibit the formation of CD10+GPR77+ CAFs and recover the chemosensitivity in vivo, leading to effective tumor control. Collectively, these findings reveal that inflammatory signaling crosstalk between TAMs and fibroblasts is responsible for the formation of the CD10+GPR77+ CAFs, suggesting CCL18–PITPNM3 signaling is a potential therapeutic target to block the activation of this specific CAF subtype and tumor chemoresistance.

5 January 2023 in Cancer Immunology Research
Verified
Journal Article
Open access
PDF file
LLLiyan Lao
Liyan Lao
WZWenfeng Zeng
Wenfeng Zeng
PHPenghan Huang
Penghan Huang
HCHuiping Chen
Huiping Chen
ZJZishuo Jia
Zishuo Jia
JLJiang Liu
Jiang Liu
The therapeutic efficacy of chemotherapy is in part a result of its ability to enhance adaptive antitumor immune responses. However, tumor cells exploit various evasion mechanisms to escape the immune attack and blunt chemosensitivity. Herein, we report that through single-cell profiling of the tumor immune microenvironment, we identified a subset of CD161-overexpressing CD8+ T cells enriched in chemoresistant tumors. CD161 engagement repressed the calcium influx and cytolytic capacity of CD8+ T cells through acid sphingomyelinase activation and ceramide generation. Targeting CD161 in adoptively transferred cytotoxic T lymphocytes enhanced antitumor immunity and reversed chemoresistance in patient-derived xenografts in vivo. Clinically, CD161 expression on CD8+ T cells was associated with chemoresistance and shortened patient survival. Our findings provide insights into novel immunosuppressive mechanisms in chemoresistance and highlight targeting CD161 as a potential therapeutic strategy.

1 January 2024 in Journal of Cancer
Verified
Journal Article
Open access
PDF file
ZLZhirong Lin
Zhirong Lin
ZLZifei Liu
Zifei Liu
ZPZhilong Pan
Zhilong Pan
YZYunyi Zhang
Yunyi Zhang
XYXinyu Yang
Xinyu Yang
JCJianing Chen
Jianing Chen
Purpose: Early growth response 1 (EGR1) is a crucial transcription factor composed of zinc finger structures, inhibitory and activating regulatory regions. We identified the biological effect and molecular mechanisms of EGR1 in breast cancer (BC).

6 October 2025 in Journal of Experimental & Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
YJYongxue Jiang
Yongxue Jiang
WZWenfeng Zeng
Wenfeng Zeng
YFYaxin Feng
Yaxin Feng
XDXiaoting Deng
Xiaoting Deng
JWJiayi Wang
Jiayi Wang
PHPenghan Huang
Penghan Huang
Background: Peripheral nerve damage is intricately linked to the progression of various solid tumors. However, its effect on antitumor immunity and precise underlying mechanisms remain poorly understood. This study aimed to elucidate the effect of peripheral nerve damage and its subsequent immune-modulating effects influence on breast cancer progression. Methods: We analyzed nerve injury markers in the TCGA-BRCA database and clinical samples. In vivo experiments were conducted using orthotopic breast cancer models with chemical sympathetic denervation (6-OHDA) or nerve lysate/neurofilament light chain (NFL) treatment, where NFL was identified as a key effector molecule through mass spectrometry screening. The tumor microenvironment was evaluated by flow cytometry, multiplex immunohistochemistry, and single-cell RNA sequencing. In vitro co-culture systems were established to investigate the effects of NFL on macrophages and CD8+ T cells, with transcriptomic profiling revealing that NFL-activated macrophage supernatants induced CD8+ T cell senescence via NF-κB signal pathway activation. Results: Peripheral nerve injury was associated with poor prognosis and immune evasion in breast cancer patients. In mouse models, chemical sympathectomy (6-OHDA) and nerve lysates injection both accelerated tumor growth, suggesting that nerve damage promotes immune escape. Single-cell RNA sequencing (scRNA-seq) further revealed that nerve injury increased tumor-associated macrophages (TAMs) proportion by promoting TAMs proliferation and attracting macrophages. The key effector molecule of nerve lysates neurofilament light chain (NFL) was identified with the TAMs proliferation effect, and intratumoral NFL administration recapitulated the pro-tumor effects of nerve damage and perfomed the same immune-modulating effects as 6-OHDA and nerve lysates. Importantly, NFL-induced TAM enrichment and remodeling promoted CD8+ T cell senescence, as evidenced by transcriptomic analysis showing NF-κB pathway activation and verified with NF-κB inhibitor (BAY 11-7082) in vitro, resulting in breast cancer immune escape. Conclusion: These findings underscore the critical role of peripheral nerve injury in reshaping the interplay between TAMs and antitumor immunity, via NFL-driven NF-κB activation and T cell dysfunction. Suggesting that neuroprotection could serve as a promising strategy to restore anticancer immunosurveillance.

25 July 2025 in Science Advances
Verified
Journal Article
Open access
JLJingxin Liu
Jingxin Liu
CZCai Zhao
Cai Zhao
JCJiahao Chen
Jiahao Chen
PZPengguihang Zeng
Pengguihang Zeng
QLQingjian Li
Qingjian Li
JDJunjun Ding
Junjun Ding
Breast cancer is the most common malignancy in females and remains the leading cause of cancer-related deaths for women worldwide. The cellular and molecular basis of breast tumorigenesis is not completely understood partly due to the lack of human research models which simulate the development of breast cancer. Here, we developed a method for generating functional mammary-like cells (MCs) from human-induced pluripotent stem cells (iPSCs). The iPSC-MCs closely resemble human primary MCs at cellular, transcriptional, and functional levels. Using this method, a breast cancer model was generated using patient-derived iPSCs harboring germline BRCA1 mutation. The patient iPSC-MCs recapitulated the transcriptome, clinical genomic alteration, and tumorigenic ability of breast cancer cells. We also identified S100P as an oncogene downstream of mutated BRCA1 that promotes cancer cell stemness and tumorigenesis. Our study establishes a promising system of breast cancer for studying the mechanism of tumorigenesis and identifying potential therapeutic targets.